Molecular Diffusion Models with Virtual Receptors

Matan Halfon, Eyal Rozenberg, Ehud Rivlin, Daniel Freedman
6/26/2024
cs.LGq-bio.BM

No confident code implementation found for this paper.

Abstract

Machine learning approaches to Structure-Based Drug Design (SBDD) have proven quite fertile over the last few years. In particular, diffusion-based approaches to SBDD have shown great promise. We present a technique which expands on this diffusion approach in two crucial ways. First, we address the size disparity between the drug molecule and the target/receptor, which makes learning more challenging and inference slower. We do so through the notion of a Virtual Receptor, which is a compressed version of the receptor; it is learned so as to preserve key aspects of the structural information of the original receptor, while respecting the relevant group equivariance. Second, we incorporate a protein language embedding used originally in the context of protein folding. We experimentally demonstrate the contributions of both the virtual receptors and the protein embeddings: in practice, they lead to both better performance, as well as significantly faster computations.

View on arXivView PDF

Code Implementations

No confident code match yet

We couldn't find an author-owned or strongly-evidenced community implementation for this paper. Any repos shown below are weak matches — verify before relying on them.

No code implementations found yet.

Know of an implementation? Let us know in the comments below!

Similar Papers

Cite this paper

@article{halfon2024molecular,
  title  = {Molecular Diffusion Models with Virtual Receptors},
  author = {Matan Halfon and Eyal Rozenberg and Ehud Rivlin and Daniel Freedman},
  year   = {2024},
  eprint = {2406.18330},
  archivePrefix = {arXiv},
  url    = {http://arxiv.org/abs/2406.18330v1}
}

Add a badge to your README

Shows whether official code is linked for this paper.

Code of Paper badge
[![Code of Paper](https://codeofpaper.com/badge/2406.18330.svg)](https://codeofpaper.com/paper/2406.18330)

Discussion